Bioactive Glass-Polycitrate Hybrid with Osteogenetic Ability Comparable to Autogenous Bone

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Current artificial bone grafts lack the osteogenic capacity of autogenous bone.
• Enhancing osteogenic and angiogenic properties is crucial for successful bone defect repair.
• Angiogenesis is vital for nutrient supply and cell survival in bone transplantation.

Purpose of the Study:

• To develop novel citrate polymer and bioactive glass (PEC-GS/BG) hybrids with enhanced osteogenic and angiogenic abilities.
• To evaluate the efficacy of PEC-GS/BG in repairing critical bone defects compared to autogenous bone.

Main Methods:

• Combination of citrate polymer and bioactive glass at the molecular level to create PEC-GS/BG hybrids.
• In vitro and in vivo studies using a rat femoral condyle critical defect model.
• Assessment of bone mineral density (BMD), angiogenesis (VEGF levels), and cell differentiation (MC3T3E-1 cells).

Main Results:

• PEC-GS/BG hybrids demonstrated bone mineral density (BMD) comparable to autogenous bone at 12 weeks post-surgery.
• Significant promotion of angiogenesis by PEC-GS/BG, evidenced by increased vascular endothelial growth factor (VEGF) release.
• Accelerated differentiation and mineralization of MC3T3E-1 cells at both protein and cellular levels.

Conclusions:

• PEC-GS/BG hybrids exhibit osteogenic performance nearly equivalent to autogenous bone in repairing bone defects.
• The developed hybrids possess superior angiogenic ability compared to autogenous bone.
• PEC-GS/BG represents a promising new material for bone repair, potentially overcoming limitations of autogenous bone grafting.